These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 25414781)

  • 1. New Insights into VEGF-A Alternative Splicing: Key Regulatory Switching in the Pathological Process.
    Dehghanian F; Hojati Z; Kay M
    Avicenna J Med Biotechnol; 2014 Oct; 6(4):192-9. PubMed ID: 25414781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of pro- and anti-angiogenic isoforms of VEGF is differentially regulated by splicing and growth factors.
    Nowak DG; Woolard J; Amin EM; Konopatskaya O; Saleem MA; Churchill AJ; Ladomery MR; Harper SJ; Bates DO
    J Cell Sci; 2008 Oct; 121(Pt 20):3487-95. PubMed ID: 18843117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alternative splicing in angiogenesis: the vascular endothelial growth factor paradigm.
    Ladomery MR; Harper SJ; Bates DO
    Cancer Lett; 2007 May; 249(2):133-42. PubMed ID: 17027147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The anti-angiogenic isoforms of VEGF in health and disease.
    Qiu Y; Hoareau-Aveilla C; Oltean S; Harper SJ; Bates DO
    Biochem Soc Trans; 2009 Dec; 37(Pt 6):1207-13. PubMed ID: 19909248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetic retinopathy is associated with a switch in splicing from anti- to pro-angiogenic isoforms of vascular endothelial growth factor.
    Perrin RM; Konopatskaya O; Qiu Y; Harper S; Bates DO; Churchill AJ
    Diabetologia; 2005 Nov; 48(11):2422-7. PubMed ID: 16193288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The alternatively spliced anti-angiogenic family of VEGF isoforms VEGFxxxb in human kidney development.
    Bevan HS; van den Akker NM; Qiu Y; Polman JA; Foster RR; Yem J; Nishikawa A; Satchell SC; Harper SJ; Gittenberger-de Groot AC; Bates DO
    Nephron Physiol; 2008; 110(4):p57-67. PubMed ID: 19039247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Alternative splicing of vascular endothelial growth factor A and ocular neovascularization].
    Fan SJ; He SZ
    Zhonghua Yan Ke Za Zhi; 2011 Apr; 47(4):373-7. PubMed ID: 21612688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The transcription factor E2F1 and the SR protein SC35 control the ratio of pro-angiogenic versus antiangiogenic isoforms of vascular endothelial growth factor-A to inhibit neovascularization in vivo.
    Merdzhanova G; Gout S; Keramidas M; Edmond V; Coll JL; Brambilla C; Brambilla E; Gazzeri S; Eymin B
    Oncogene; 2010 Sep; 29(39):5392-403. PubMed ID: 20639906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Balance of pro- versus anti-angiogenic splice isoforms of vascular endothelial growth factor as a regulator of neuroblastoma growth.
    Peiris-Pagès M; Harper SJ; Bates DO; Ramani P
    J Pathol; 2010 Oct; 222(2):138-47. PubMed ID: 20662003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Splicing factor polymorphisms, the control of VEGF isoforms and association with angiogenic eye disease.
    Carter JG; Cherry J; Williams K; Turner S; Bates DO; Churchill AJ
    Curr Eye Res; 2011 Apr; 36(4):328-35. PubMed ID: 21309690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VEGF gene alternative splicing: pro- and anti-angiogenic isoforms in cancer.
    Biselli-Chicote PM; Oliveira AR; Pavarino EC; Goloni-Bertollo EM
    J Cancer Res Clin Oncol; 2012 Mar; 138(3):363-70. PubMed ID: 22045472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of VEGF-A Alternative Splicing as a Novel Treatment in Chronic Kidney Disease.
    Stevens M; Oltean S
    Genes (Basel); 2018 Feb; 9(2):. PubMed ID: 29462869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VEGF(121)b, a new member of the VEGF(xxx)b family of VEGF-A splice isoforms, inhibits neovascularisation and tumour growth in vivo.
    Rennel ES; Varey AH; Churchill AJ; Wheatley ER; Stewart L; Mather S; Bates DO; Harper SJ
    Br J Cancer; 2009 Oct; 101(7):1183-93. PubMed ID: 19707198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The VEGF-A exon 8 splicing-sensitive fluorescent reporter mouse is a novel tool to assess the effects of splicing regulatory compounds
    Stevens M; Star E; Lee M; Innes E; Li L; Bowler E; Harper S; Bates DO; Oltean S
    RNA Biol; 2019 Dec; 16(12):1672-1681. PubMed ID: 31432737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of vascular endothelial growth factor (VEGF) splicing from pro-angiogenic to anti-angiogenic isoforms: a novel therapeutic strategy for angiogenesis.
    Nowak DG; Amin EM; Rennel ES; Hoareau-Aveilla C; Gammons M; Damodoran G; Hagiwara M; Harper SJ; Woolard J; Ladomery MR; Bates DO
    J Biol Chem; 2010 Feb; 285(8):5532-40. PubMed ID: 19906640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular diversity of VEGF-A as a regulator of its biological activity.
    Woolard J; Bevan HS; Harper SJ; Bates DO
    Microcirculation; 2009 Oct; 16(7):572-92. PubMed ID: 19521900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A drug-repositioning screen using splicing-sensitive fluorescent reporters identifies novel modulators of VEGF-A splicing with anti-angiogenic properties.
    Star E; Stevens M; Gooding C; Smith CWJ; Li L; Ayine ML; Harper SJ; Bates DO; Oltean S
    Oncogenesis; 2021 May; 10(5):36. PubMed ID: 33941763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of VEGF-A(xxx)b isoforms in human tissues.
    Bates DO; Mavrou A; Qiu Y; Carter JG; Hamdollah-Zadeh M; Barratt S; Gammons MV; Millar AB; Salmon AH; Oltean S; Harper SJ
    PLoS One; 2013; 8(7):e68399. PubMed ID: 23935865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VEGF Splicing and the Role of VEGF Splice Variants: From Physiological-Pathological Conditions to Specific Pre-mRNA Splicing.
    Guyot M; Pagès G
    Methods Mol Biol; 2015; 1332():3-23. PubMed ID: 26285742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of VEGF(xxx)b, the inhibitory isoforms of VEGF, in malignant melanoma.
    Pritchard-Jones RO; Dunn DB; Qiu Y; Varey AH; Orlando A; Rigby H; Harper SJ; Bates DO
    Br J Cancer; 2007 Jul; 97(2):223-30. PubMed ID: 17595666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.